1954
DOI: 10.1021/ac60087a023
|View full text |Cite
|
Sign up to set email alerts
|

Behavior of Condensed Phosphates in Anion-Exchange Chromatography

Abstract: 505tween actual composition and the experimental mean, however, are only -7.84% for the glutamic acid, +9.21% for lysine, and +8.24% for glycine.Analytical data on the amino acid composition of crystalline proteins such as d-lactoglobulin (Table II) and bovine serum albumin when determined by this method have been in good agreement with previously published (12, 13) values. In general, the procedures which have been described provide a less tedious, more rapid, and reasonably accurate approach to the analysis … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
26
1
1

Year Published

1960
1960
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 130 publications
(28 citation statements)
references
References 20 publications
0
26
1
1
Order By: Relevance
“…PAH is a commercially available, weak polycation (effective pK a = 8.5 40 ) that, among its many other applications, is already used in its covalently cross-linked form as an oral drug for patients with chronic kidney disease. 41 Similarly, PPi (pK a,2 = 2.3, pK a,3 = 6.6, and pK a,4 = 9.3) and TPP (pK a,3 = 2.8, pK a,4 = 6.5, and pK a,5 = 9.2) are tetravalent and pentavalent polyprotic acids, 42 which are both on the U.S. Food and Drug Administration's generally recognized as safe (GRAS) list. Because of their biocompatibility, they are used (typically as sodium salts) as both food additives 43−45 and ionic cross-linkers for colloidal drug carriers.…”
Section: Introductionmentioning
confidence: 99%
“…PAH is a commercially available, weak polycation (effective pK a = 8.5 40 ) that, among its many other applications, is already used in its covalently cross-linked form as an oral drug for patients with chronic kidney disease. 41 Similarly, PPi (pK a,2 = 2.3, pK a,3 = 6.6, and pK a,4 = 9.3) and TPP (pK a,3 = 2.8, pK a,4 = 6.5, and pK a,5 = 9.2) are tetravalent and pentavalent polyprotic acids, 42 which are both on the U.S. Food and Drug Administration's generally recognized as safe (GRAS) list. Because of their biocompatibility, they are used (typically as sodium salts) as both food additives 43−45 and ionic cross-linkers for colloidal drug carriers.…”
Section: Introductionmentioning
confidence: 99%
“…The values of k~? , k64, 1~53, and k42 indicate that reaction (9) appears to be ncgligible. Similar results obtained with short- chain polyphosphates led Thilo** to doubt the occurrence of reaction (9) altogether.…”
Section: Discussionmentioning
confidence: 99%
“…, k64, 1~53, and k42 indicate that reaction (9) appears to be ncgligible. Similar results obtained with short- chain polyphosphates led Thilo** to doubt the occurrence of reaction (9) altogether. However, rate constants for reaction (9) determined on longchain polyphosphates, described in the following paper,Ig are of the order of 0.1 X 10W4 min-'.…”
Section: Discussionmentioning
confidence: 99%
“…can be obtained by dividing the resin bed height by the value of P. The column height required for a specific separation of two solutes can be approximated by [47]: This form of the equation is probably the easiest to calculate from experimental data.…”
Section: Chromatographic Theorymentioning
confidence: 99%